Keenan, C., Nichols, K. E., & Albeituni, S. (2021). Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis. Front Immunol.
Citação norma ChicagoKeenan, Camille, Kim E. Nichols, and Sabrin Albeituni. "Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis." Front Immunol 2021.
Citação norma MLAKeenan, Camille, Kim E. Nichols, and Sabrin Albeituni. "Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis." Front Immunol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.